ArticleMolecular oncology2008

The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr-Abl activity in chronic myeloid leukemia.

Oliver Hantschel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.